- Home
- SNSE vs INLF Comparison
SNSE vs INLF Comparison
Compare SNSE & INLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- INLF
- Stock Information
- Founded
- SNSE 2005
- INLF 2016
- Country
- SNSE United States
- INLF China
- Employees
- SNSE N/A
- INLF N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- INLF Industrial Machinery/Components
- Sector
- SNSE Health Care
- INLF Industrials
- Exchange
- SNSE Nasdaq
- INLF Nasdaq
- Market Cap
- SNSE 10.3M
- INLF 10.9M
- IPO Year
- SNSE 2021
- INLF 2025
- Fundamental
- Price
- SNSE $8.60
- INLF $0.58
- Analyst Decision
- SNSE Strong Buy
- INLF
- Analyst Count
- SNSE 5
- INLF 0
- Target Price
- SNSE $72.50
- INLF N/A
- AVG Volume (30 Days)
- SNSE 39.5K
- INLF 61.9K
- Earning Date
- SNSE 11-14-2025
- INLF 09-29-2025
- Dividend Yield
- SNSE N/A
- INLF N/A
- EPS Growth
- SNSE N/A
- INLF N/A
- EPS
- SNSE N/A
- INLF N/A
- Revenue
- SNSE N/A
- INLF $19,332,282.00
- Revenue This Year
- SNSE N/A
- INLF N/A
- Revenue Next Year
- SNSE N/A
- INLF N/A
- P/E Ratio
- SNSE N/A
- INLF N/A
- Revenue Growth
- SNSE N/A
- INLF 33.11
- 52 Week Low
- SNSE $5.00
- INLF $0.55
- 52 Week High
- SNSE $18.35
- INLF $21.00
- Technical
- Relative Strength Index (RSI)
- SNSE 44.73
- INLF 23.50
- Support Level
- SNSE $8.37
- INLF $0.57
- Resistance Level
- SNSE $9.42
- INLF $0.61
- Average True Range (ATR)
- SNSE 1.08
- INLF 0.03
- MACD
- SNSE -0.02
- INLF -0.01
- Stochastic Oscillator
- SNSE 33.45
- INLF 12.84
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. The company portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.